The ISPOR Latin America Consortium is comprised of professionals interested in promoting health economics and outcomes research (HEOR) excellence to improve healthcare decision making in Latin America and globally. The Latin America consortium provides a platform for information-sharing and institutional collaboration on HEOR and health policy, facilitating professional networking opportunities through scientific activities and global ISPOR initiatives.
- The highly anticipated webinar titled, “MCDA Application to Oncology”, will be presented on Tuesday, November 27, 2018. The webinar, hosted by the ISPOR Latin America Consortium Health Technology Producers (Industry) Committee, is the third and final installment in a series of webinars with a focus on MCDA. Consortium and regional chapters members are encouraged to participate
- ISPOR Latin America 2019 scheduled for September 2019 in Bogotá, Colombia - look for more information to come
- Welcome to the 2018-2020 Latin America Consortium Committee Chairs: Diego Rosselli, MD, MEd, MHP, Executive Committee; Rubén Rojas, MSc, Education Committee; Marcelo Nita, MD, MSc, PhD, Publications Committee; Claudia Brabata, MBA, MSc, Health Technology Producers (Industry) Committee!
Value In Health Regional Issues
Value in Health Regional Issues a MEDLINE®-indexed, scientific, peer-reviewed journal to encourage and enhance the science of pharmacoeconomic/health economic and health outcomes research and its use in healthcare decisions in Latin America. Manuscript submission is open year-round.
News Across Latin America
News Across Latin America is the Latin America Consortium newsletter.
Therapeutic and Diagnostic Device Outcomes Research
Therapeutic and Diagnostic Device Outcomes Research is now available in Portuguese.
ISPOR's Health Technology Assessment Central is a comprehensive repository of resources and tools to support health technology assessment (HTA). HTA Central helps bridge the gap between health economics and outcomes research and other disciplines that inform HTA and healthcare decisions.
The ISPOR Global Healthcare Systems Road Map provides information on country/region-specific decision-making processes for regulatory (market access) approval, reimbursement and economic evaluations of pharmaceuticals and medical devices and diagnostics.
ISPOR recognizes members and thought leaders in the field of health economics and outcomes research through a wide variety of scientific achievement and leadership awards, research presentation awards, and conference travel grants.